Lessons for tuberculosis vaccines from respiratory virus infection

References

• WHO. Global Tuberculosis Control – Surveillance, Planning, Financing. WHO/HTM/TB/2008.393 (2008).
   Google Scholar
• Friedland G. Tuberculosis, drug resistance, and HIV/AIDS: a triple threat. Curr. Infect. Dis. Rep.9(3), 252–261 (2007).
   PubMedGoogle Scholar
• Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet346(8986), 1339–1345 (1995).
   PubMed Web of Science ®Google Scholar
• Openshaw P. T cells take the inside track. Nat. Med.12(6), 614–615 (2006).
   PubMed Web of Science ®Google Scholar
• Liang S, Mozdzanowska K, Palladino G, Gerhard W. Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. J. Immunol.152(4), 1653–1661 (1994).
   PubMed Web of Science ®Google Scholar
• Reece ST, Kaufmann SH. Rational design of vaccines against tuberculosis directed by basic immunology. Int. J. Med. Microbiol.298(1–2), 143–150 (2008).
   PubMed Web of Science ®Google Scholar
• Rook GA, Dheda K, Zumla A. Immune responses to tuberculosis in developing countries: implications for new vaccines. Nat. Rev. Immunol.5(8), 661–667 (2005).
   PubMed Web of Science ®Google Scholar
• Tedder TF, Steeber DA, Chen A, Engel P. The selectins: vascular adhesion molecules. FASEB J.9(10), 866–873 (1995).
   PubMed Web of Science ®Google Scholar
• Doerschuk CM. Leukocyte trafficking in alveoli and airway passages. Respir. Res.1(3), 136–140 (2000).
   PubMedGoogle Scholar
• Hogan RJ, Zhong W, Usherwood EJ et al. Protection from respiratory virus infections can be mediated by antigen-specific CD4+ T cells that persist in the lungs. J. Exp. Med.193(8), 981–986 (2001).
   PubMed Web of Science ®Google Scholar
• Legge KL, Braciale TJ. Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection. Immunity18(2), 265–277 (2003).
   PubMed Web of Science ®Google Scholar
• Lawrense CW, Braciale TJ. Activation, differentiation, and migration of naive virus-specific CD8+ T cells during pulmonary influenza virus infection. J. Immunol.173(2), 1209–1218 (2004).
   PubMed Web of Science ®Google Scholar
• Feng CG, Britton WJ, Palendira U et al. Up-regulation of VCAM-1 and differential expansion of β integrin-expressing T lymphocytes are associated with immunity to pulmonary Mycobacterium tuberculosis infection. J. Immunol.164(9), 4853–4860 (2000).
   PubMed Web of Science ®Google Scholar
• Hogan RJ, Usherwood EJ, Zhong W et al. Activated antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections. J. Immunol.166(3), 1813–1822 (2001).
   PubMed Web of Science ®Google Scholar
• Ostler T, Hussell T, Surh CD, Openshaw P, Ehl S. Long-term persistence and reactivation of T cell memory in the lung of mice infected with respiratory syncytial virus. Eur. J. Immunol.31(9), 2574–2582 (2001).
   PubMed Web of Science ®Google Scholar
• Marshall DR, Turner SJ, Belz GT et al. Measuring the diaspora for virus-specific CD8+ T cells. Proc. Natl Acad. Sci. USA98(11), 6313–6318 (2001).
   PubMed Web of Science ®Google Scholar
• Debes GF, Arnold CN, Young AJ et al. Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues. Nat. Immunol.6(9), 889–894 (2005).
   PubMed Web of Science ®Google Scholar
• Bromley SK, Thomas SY, Luster AD. Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat. Immunol.6(9), 895–901 (2005).
   PubMed Web of Science ®Google Scholar
• Hogan RJ, Cauley LS, Ely KH et al. Long-term maintenance of virus-specific effector memory CD8+ T cells in the lung airways depends on proliferation. J. Immunol.169(9), 4976–4981 (2002).
   PubMed Web of Science ®Google Scholar
• Zammit DJ, Turner DL, Klonowski KD, Lefrancois L, Cauley LS. Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration. Immunity24(4), 439–449 (2006).
   PubMed Web of Science ®Google Scholar
• Julia V, Hessel EM, Malherbe L et al. A restricted subset of dendritic cells captures airborne antigens and remains able to activate specific T cells long after antigen exposure. Immunity16(2), 271–283 (2002).
   PubMed Web of Science ®Google Scholar
• Mora JR, Cheng G, Picarella D et al. Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues. J. Exp. Med.201(2), 303–316 (2005).
   PubMed Web of Science ®Google Scholar
• Holt PG, Strickland DH, Wikstrom ME, Jahnsen FL. Regulation of immunological homeostasis in the respiratory tract. Nat. Rev. Immunol.8(2), 142–152 (2008).
   PubMed Web of Science ®Google Scholar
• Moyron-Quiroz JE, Rangel-Moreno J, Kusser K et al. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat. Med.10(9), 927–934 (2004).
   PubMed Web of Science ®Google Scholar
• Xu B, Wagner N, Pham LN et al. Lymphocyte homing to bronchus-associated lymphoid tissue (BALT) is mediated by L-selectin/PNAd, α4β1 integrin/VCAM-1, and LFA-1 adhesion pathways. J. Exp. Med.197(10), 1255–1267 (2003).
   PubMed Web of Science ®Google Scholar
• Galkina E, Thatte J, Dabak V et al. Preferential migration of effector CD8+ T cells into the interstitium of the normal lung. J. Clin. Invest.115(12), 3473–3483 (2005).
   PubMed Web of Science ®Google Scholar
• Ray SJ, Franki SN, Pierce RH et al. The collagen binding α1β1 integrin VLA-1 regulates CD8 T cell-mediated immune protection against heterologous influenza infection. Immunity20(2), 167–179 (2004).
   PubMed Web of Science ®Google Scholar
• Ainslie MP, McNulty CA, Huynh T, Symon FA, Wardlaw AJ. Characterisation of adhesion receptors mediating lymphocyte adhesion to bronchial endothelium provides evidence for a distinct lung homing pathway. Thorax57(12), 1054–1059 (2002).
   PubMed Web of Science ®Google Scholar
• Abitorabi MA, Mackay CR, Jerome EH et al. Differential expression of homing molecules on recirculating lymphocytes from sheep gut, peripheral, and lung lymph. J. Immunol.156(9), 3111–3117 (1996).
   PubMed Web of Science ®Google Scholar
• Zabel BA, Agace WW, Campbell JJ et al. Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis. J. Exp. Med.190(9), 1241–1256 (1999).
   PubMed Web of Science ®Google Scholar
• Campbell JJ, Bowman EP, Murphy K et al. 6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3β receptor CCR7. J. Cell Biol.141(4), 1053–1059 (1998).
   PubMed Web of Science ®Google Scholar
• Campbell JJ, Brightling CE, Symon FA et al. Expression of chemokine receptors by lung T cells from normal and asthmatic subjects. J. Immunol.166(4), 2842–2848 (2001).
   PubMed Web of Science ®Google Scholar
• Morgan AJ, Guillen C, Symon FA et al. Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease. Clin. Exp. Allergy35(12), 1572–1580 (2005).
   PubMed Web of Science ®Google Scholar
• Goonetilleke NP, McShane H, Hannan CM et al. Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette–Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara. J. Immunol.171(3), 1602–1609 (2003).
   PubMed Web of Science ®Google Scholar
• Santosuosso M, McCormick S, Zhang X, Zganiacz A, Xing Z. Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis. Infect. Immun.74(8), 4634–464 (2006).
   PubMed Web of Science ®Google Scholar
• Santosuosso M, Zhang X, McCormick S et al. Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen. J. Immunol.174(12), 7986–7994 (2005).
   PubMed Web of Science ®Google Scholar
• Wang J, Thorson L, Stokes RW et al. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis. J. Immunol.173(10), 6357–6365 (2004).
   PubMed Web of Science ®Google Scholar
• Marzo AL, Yagita H, Lefrancois L. Cutting edge: migration to nonlymphoid tissues results in functional conversion of central to effector memory CD8 T cells. J. Immunol.179(1), 36–40 (2007).
   PubMed Web of Science ®Google Scholar
• Agrewala JN, Brown DM, Lepak NM et al. Unique ability of activated CD4+ T cells but not rested effectors to migrate to non-lymphoid sites in the absence of inflammation. J. Biol. Chem.282(9), 6106–6115 (2007).
   PubMed Web of Science ®Google Scholar
• Radosevic K, Wieland CW, Rodriguez A et al. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of γ interferon. Infect. Immun.75(8), 4105–4115 (2007).
   PubMed Web of Science ®Google Scholar
• Santosuosso M, McCormick S, Roediger E et al. Mucosal luminal manipulation of T cell geography switches on protective efficacy by otherwise ineffective parenteral genetic immunization. J. Immunol.178(4), 2387–2395 (2007).
   PubMed Web of Science ®Google Scholar
• Jung YJ, Ryan L, LaCourse R, North RJ. Properties and protective value of the secondary versus primary T helper type 1 response to airborne Mycobacterium tuberculosis infection in mice. J. Exp. Med.201(12), 1915–1924 (2005).
   PubMed Web of Science ®Google Scholar
• Ehrt S, Shiloh MU, Ruan J et al. A novel antioxidant gene from Mycobacterium tuberculosis. J. Exp. Med.186(11), 1885–1896 (1997).
   PubMed Web of Science ®Google Scholar
• Armstrong JA, Hart PD. Phagosome–lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. J. Exp. Med.142(1), 1–16 (1975).
   PubMed Web of Science ®Google Scholar
• van der Wel N, Hava D, Houben D et al.M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell129(7), 1287–1298 (2007).
   PubMed Web of Science ®Google Scholar
• Forbes EK, Sander C, Ronan EO et al. Multifunctional, high-level cytokine producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice. J. Immunol. (2008) (In Press).
   Google Scholar
• Minne A, Louahed J, Mehauden S et al. The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response. Immunology122(3), 316–325 (2007).
   PubMed Web of Science ®Google Scholar
• Corbett M, Bogers WM, Heeney JL et al. Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic. Proc. Natl Acad. Sci. USA105(6), 2046–2051 (2008).
   PubMed Web of Science ®Google Scholar
• Johnson PR, Feldman S, Thompson JM, Mahoney JD, Wright PF. Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine. J. Infect. Dis.154(1), 121–127 (1986).
   PubMed Web of Science ®Google Scholar
• Dilraj A, Cutts FT, de Castro JF et al. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial. Lancet355(9206), 798–803 (2000).
   PubMed Web of Science ®Google Scholar
• Rosenthal SR, McEnery JT, Raisys N. Aerogenic BCG vaccination against tuberculosis in animal and human subjects. J. Asthma Res.5(4), 309–323 (1968).
   PubMedGoogle Scholar
• Garcia-Contreras L, Wong YL, Muttil P et al. Immunization by a bacterial aerosol. Proc. Nat. Acad. Sci. USA105(12), 4656–4660 (2008).
   PubMed Web of Science ®Google Scholar
• Dietrich J, Andersen C, Rappuoli R et al. Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette–Guerin immunity. J. Immunol.177(9), 6353–6360 (2006).
   PubMed Web of Science ®Google Scholar
• Taylor JL, Turner OC, Basaraba RJ et al. Pulmonary necrosis resulting from DNA vaccination against tuberculosis. Infect. Immun.71(4), 2192–2198 (2003).
   PubMed Web of Science ®Google Scholar
• Kim EY, Battaile JT, Patel AC et al. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat. Med.14(6), 633–640 (2008).
   PubMed Web of Science ®Google Scholar
• Egilmez NK, Kilinc MO, Gu T, Conway TF. Controlled-release particulate cytokine adjuvants for cancer therapy. Endocr. Metab. Immune Disord. Drug Targets7(4), 266–270 (2007).
   PubMedGoogle Scholar
• Liang MT, Davies NM, Blanchfield JT, Toth I. Particulate systems as adjuvants and carriers for peptide and protein antigens. Curr. Drug Deliv.3(4), 379–388 (2006).
   PubMedGoogle Scholar
• Iwata M, Hirakiyama A, Eshima Y et al. Retinoic acid imprints gut-homing specificity on T cells. Immunity21(4), 527–538 (2004).
   PubMed Web of Science ®Google Scholar
• Sigmundsdottir H, Pan J, Debes GF et al. DCs metabolize sunlight-induced vitamin D3 to ‘program’ T cell attraction to the epidermal chemokine CCL27. Nat. Immunol.8(3), 285–293 (2007).
   PubMed Web of Science ®Google Scholar
• Khader SA, Bell GK, Pearl JE et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol.8(4), 369–377 (2007).
   PubMed Web of Science ®Google Scholar
• Tatsis N, Lin SW, Harris-McCoy K et al. Multiple immunizations with adenovirus and MVA vectors improve CD8+ T cell functionality and mucosal homing. Virology367(1), 156–167 (2007).
   PubMed Web of Science ®Google Scholar
• Karonga Prevention Trial Group. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Lancet348(9019), 17–24 (1996).
   PubMed Web of Science ®Google Scholar
• Grode L, Kursar M, Fensterle J, Kaufmann SH, Hess J. Cell-mediated immunity induced by recombinant Mycobacterium bovis bacille Calmette–Guerin strains against an intracellular bacterial pathogen: importance of antigen secretion or membrane-targeted antigen display as lipoprotein for vaccine efficacy. J. Immunol.168(4), 1869–1876 (2002).
   PubMed Web of Science ®Google Scholar
• Wu Y, Woodworth JS, Shin DS, Morris S, Behar SM. Vaccine-elicited 10-kilodalton filtrate protein-specific CD8+ T cells are sufficient to mediate protection against Mycobacterium tuberculosis infection. Infect. Immun.76(5), 2249–2255 (2008).
   PubMed Web of Science ®Google Scholar
• Sambandamurthy VK, Derrick SC, Jalapathy KV et al. Long-term protection against tuberculosis following vaccination with a severely attenuated double lysine and pantothenate auxotroph of Mycobacterium tuberculosis. Infect. Immun.73(2), 1196–1203 (2005).
   PubMed Web of Science ®Google Scholar
• Olsen AW, Hansen PR, Holm A, Andersen P. Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. Eur. J. Immunol.30(6), 1724–1732 (2000).
   PubMed Web of Science ®Google Scholar
• Baldwin SL, D’Souza C, Roberts AD et al. Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. Infect. Immun.66(6), 2951–2959 (1998).
   PubMed Web of Science ®Google Scholar
• Lin MY, Ottenhoff TH. Not to wake a sleeping giant: new insights into host–pathogen interactions identify new targets for vaccination against latent Mycobacterium tuberculosis infection. Biol. Chem.https://doi.org/10.1515/BC.2008.057 doi:10.1515/BC.2008.057 (2008) (Epub ahead of print).
   Google Scholar
• McShane H, Pathan AA, Sander CR et al. Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat. Med.10(11), 1240–1244 (2004).
   PubMed Web of Science ®Google Scholar